Skip to content

RNAM

Avidity Biosciences, Inc.

NASDAQ · Healthcare · Biotechnology · US

$72.86
+0.05%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue36.0M18.8M10.9M9.6M9.2M
Cost of Revenue3.0M4.2M2.8M2.1M1.4M
Gross Profit32.9M14.6M8.1M7.5M7.8M
Operating Expenses
R&D Expense353.5M559.2M303.6M191.0M150.4M
SG&A Expense162.6M201.4M83.5M52.1M36.3M
General & Admin Expense
Selling & Marketing Expense
Other Expenses
Total Operating Expenses516.1M760.5M387.1M243.1M186.8M
Cost and Expenses519.2M764.7M389.8M245.2M188.1M
Operating Income (EBIT)(483.2M)(745.9M)(378.9M)(235.6M)(178.9M)
Non-Operating
Interest Income34.7M63.3M56.9M24.0M5.0M
Interest Expense
Net Interest Income34.7M63.3M56.9M24.0M5.0M
Other Non-Op Income/Expense34.8M61.3M56.6M23.4M4.9M
Non-Operating Income (excl Interest)(647.0K)
EBT (Pre-Tax Income)(448.4M)(684.6M)(322.3M)(212.2M)(174.0M)
Income Tax Expense
Bottom Line
Net Income(448.4M)(684.6M)(322.3M)(212.2M)(174.0M)
Earnings from Cont. Ops(448.4M)(684.6M)(322.3M)(212.2M)(174.0M)
Earnings from Discont. Ops
Bottom Line Net Income(448.4M)(684.6M)(322.3M)(212.2M)(174.0M)
Per Share
Basic EPS($5.00)($4.97)($2.89)($2.91)($3.34)
Diluted EPS($5.00)($4.97)($2.89)($2.91)($3.34)
Revenue Per Share$2.10$0.14$0.10$0.13$0.18
Shares
Basic Shares Outstanding17.1M137.7M111.6M73.0M52.2M
Diluted Shares Outstanding17.1M137.7M111.6M73.0M52.2M
Profitability Metrics
EBITDA(479.5M)(741.8M)(376.2M)(233.5M)(177.5M)
D&A3.0M4.2M2.8M2.1M1.4M
EBIT(482.5M)(745.9M)(378.9M)(235.6M)(178.9M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026